Us Bancorp \De\ Akero Therapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,711 shares of AKRO stock, worth $52,425. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,711

Previous 1,761 2.84%

Holding current value

$52,425

Previous $41,000 19.51%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$21.45 - $29.34 $1,072 - $1,467	-50 Reduced 2.84%	1,711 $49,000
Q2 2024 Aug 06, 2024	BUY	$18.31 - $24.62 $878 - $1,181	48 Added 2.8%	1,761 $41,000
Q1 2024 May 07, 2024	SELL	$17.76 - $31.18 $26,000 - $45,647	-1,464 Reduced 46.08%	1,713 $43,000
Q4 2023 Feb 09, 2024	BUY	$11.38 - $50.33 $10,321 - $45,649	907 Added 39.96%	3,177 $74,000
Q3 2023 Nov 03, 2023	SELL	$41.19 - $52.25 $57,295 - $72,679	-1,391 Reduced 38.0%	2,270 $114,000
Q2 2023 Aug 09, 2023	BUY	$36.89 - $56.88 $16,084 - $24,799	436 Added 13.52%	3,661 $170,000
Q1 2023 May 09, 2023	SELL	$37.27 - $50.24 $156,832 - $211,409	-4,208 Reduced 56.61%	3,225 $123,000
Q4 2022 Feb 13, 2023	BUY	$33.44 - $54.8 $63,268 - $103,681	1,892 Added 34.15%	7,433 $407,000
Q3 2022 Oct 27, 2022	BUY	$10.15 - $34.05 $33,352 - $111,888	3,286 Added 145.72%	5,541 $189,000
Q2 2022 Aug 01, 2022	BUY	$8.0 - $15.01 $7,032 - $13,193	879 Added 63.88%	2,255 $21,000
Q1 2022 May 11, 2022	BUY	$12.97 - $22.26 $3,579 - $6,143	276 Added 25.09%	1,376 $20,000
Q3 2021 Nov 10, 2021	SELL	$18.65 - $25.46 $36,013 - $49,163	-1,931 Reduced 63.71%	1,100 $25,000
Q2 2021 Aug 05, 2021	SELL	$24.81 - $32.35 $24,040 - $31,347	-969 Reduced 24.23%	3,031 $75,000
Q1 2021 Apr 28, 2021	BUY	$24.04 - $34.19 $96,160 - $136,760	4,000 New	4,000 $116,000
Q3 2020 Nov 10, 2020	SELL	$30.79 - $39.92 $23,092 - $29,940	-750 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$12.8 - $27.05 $9,600 - $20,287	750 New	750 $16,000

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.42B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account